Search research articles
Contact Us
Filters
Showing results (101-110 of 178) with videos related to
Page
of 18
Sort By:
Clinical Endocrinology
|
July 24, 2014
Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome
Iris Crespo, Granell-Moreno Esther, Alicia Santos, et al.
Endocrine Connections
|
September 23, 2025
Validation and implementation of the Dutch PHPQoL for primary hyperparathyroidism
Jaimie L H Zhang, Abbey Schepers, Jaap F Hamming, et al.
Pituitary
|
April 15, 2014
Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing's syndrome
María-José Barahona, Eugenia Resmini, David Viladés, et al.
Advances in Therapy
|
March 14, 2024
Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Dermot O'Toole, Pamela L Kunz, Susan M Webb, et al.
European Journal of Endocrinology
|
April 19, 2014
Telomere length analysis in Cushing's syndrome
Anna Aulinas, María-José Ramírez, María-José Barahona, et al.
Plos One
|
March 24, 2015
Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome
Anna Aulinas, María-José Ramírez, María-José Barahona, et al.
Cardiovascular Research
|
September 29, 2007
Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair
Ramón Martínez-Mármol, Miren David, Rosario Sanches, et al.
Endocrine
|
September 25, 2015
A specific nursing educational program in patients with Cushing's syndrome
M Antonia Martínez-Momblán, Carmen Gómez, Alicia Santos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 22, 2009
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma
Susan M Webb, Daojun Mo, Steven W J Lamberts, et al.
Advances in Therapy
|
December 11, 2022
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Dermot O'Toole, Pamela L Kunz, Susan M Webb, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 178) with videos related to
Sort By:
Page
of 18
Clinical Endocrinology
|
July 24, 2014
Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome
Iris Crespo, Granell-Moreno Esther, Alicia Santos, et al.
Endocrine Connections
|
September 23, 2025
Validation and implementation of the Dutch PHPQoL for primary hyperparathyroidism
Jaimie L H Zhang, Abbey Schepers, Jaap F Hamming, et al.
Pituitary
|
April 15, 2014
Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing's syndrome
María-José Barahona, Eugenia Resmini, David Viladés, et al.
Advances in Therapy
|
March 14, 2024
Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Dermot O'Toole, Pamela L Kunz, Susan M Webb, et al.
European Journal of Endocrinology
|
April 19, 2014
Telomere length analysis in Cushing's syndrome
Anna Aulinas, María-José Ramírez, María-José Barahona, et al.
Plos One
|
March 24, 2015
Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome
Anna Aulinas, María-José Ramírez, María-José Barahona, et al.
Cardiovascular Research
|
September 29, 2007
Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair
Ramón Martínez-Mármol, Miren David, Rosario Sanches, et al.
Endocrine
|
September 25, 2015
A specific nursing educational program in patients with Cushing's syndrome
M Antonia Martínez-Momblán, Carmen Gómez, Alicia Santos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 22, 2009
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma
Susan M Webb, Daojun Mo, Steven W J Lamberts, et al.
Advances in Therapy
|
December 11, 2022
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Dermot O'Toole, Pamela L Kunz, Susan M Webb, et al.
Page
of 18